K Bjordal,
A de Graeff,
P M Fayers,
E Hammerlid,
C van Pottelsberghe,
D Curran,
M Ahlner-Elmqvist,
E J Maher,
J W Meyza,
A Brédart,
A L Söderholm,
J J Arraras,
J S Feine,
H Abendstein,
R P Morton,
T Pignon, P Huguenin,
A Bottomly,
S Kaasa
[show abstract]
[hide abstract]
ABSTRACT: This study tests the reliability and validity of the European Organization for Research and Treatment of Cancer (EORTC) head and neck cancer module (QLQ-H&N35) and version 3.0 of the EORTC Core Questionnaire (QLQ-C30) in 622 head and neck cancer patients from 12 countries. The patients completed the QLQ-C30, the QLQ-H&N35 and a debriefing questionnaire before antineoplastic treatment or at a follow-up. 232 patients receiving treatment completed a second questionnaire after treatment. Compliance was high and the questionnaire was well accepted by the patients. Multitrait scaling analysis confirmed the proposed scale structure of the QLQ-H&N35. The QLQ-H&N35 was responsive to differences between disease status, site and patients with different Karnofsky performance status, and to changes over time. The new physical functioning scale (with a four-point response format) of version 3.0 of the QLQ-C30 was shown to be more reliable than previous versions. Thus, the QLQ-H&N35, in conjunction with the QLQ-C30, appears to be reliable, valid and applicable to broad multicultural samples of head and neck cancer patients.
European Journal of Cancer 10/2000; 36(14):1796-807. · 5.54 Impact Factor
